Feb 15, 2012 - Blog by Ingrid Evans | Share
Dava Pharmaceuticals Whistleblower Case Settles for $11 Million PRWeb Dava Pharmaceuticals, Inc., has agreed to an $11 million settlement in response to allegations of healthcare fraud. The allegations relate to a false misclassification of certain drugs: Cefdinir, Clarithromycin, and Methotrexate. The alleged misclassification of these drugs as “non-innovator” drugs as […]